Vaccitech

NASDAQ: VACC · Real-Time Price · USD
5.00
0.51 (11.36%)
At close: Nov 06, 2023, 10:00 PM

Vaccitech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Revenue
14.97M 44.7M 268K
Cost of Revenue
n/a 42.35M 20.37M
Gross Profit
n/a 2.35M -20.1M
Operating Income
1.18M -3.45M -45.22M
Interest Income
2.68M 3.1M 2K
Pretax Income
-61.23M 850K -51.14M
Net Income
-61.07M 5.34M -51.11M
Selling & General & Admin
29.67M 6.39M 25.12M
Research & Development
42.24M 41.11M 16.37M
Other Expenses
12.21M 567K 332K
Operating Expenses
84.11M 47.5M 41.49M
Interest Expense
-53K 19K 2.67M
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
n/a 47.5M 41.49M
Income Tax Expense
-153K -4.47M -28K
Shares Outstanding (Basic)
39.35M 37.25M 25.89M
Shares Outstanding (Diluted)
39.35M 38.17M 25.89M
EPS (Basic)
-1.55 0.14 -1.97
EPS (Diluted)
-1.55 0.14 -1.97
EBITDA
1.18M 869K -45.22M
EBIT
n/a 869K -48.47M
Depreciation & Amortization
n/a 4.32M 4.33M